Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05739812
What this trial is testing

The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery

Who this might be right for
Renal Cell CarcinomaAdrenal TumorNonfunctioning Kidney+11 more
The Affiliated Hospital of Qingdao University 100
Testing effectiveness (Phase 2)Ended earlyNCT06884683
What this trial is testing

Nivolumab Plus Metformin in Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 12
Testing effectiveness (Phase 2)Study completedNCT01034631
What this trial is testing

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Hoosier Cancer Research Network 154
Testing effectiveness (Phase 2)Ended earlyNCT03456401
What this trial is testing

Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study)

Who this might be right for
Renal Cancer Cell
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 18
Not applicableUnknownNCT04177056
What this trial is testing

Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief

Who this might be right for
Bone MetastasesProstate CancerBreast Cancer+2 more
Hamilton Health Sciences Corporation 40
Large-scale testing (Phase 3)Looking for participantsNCT05738694
What this trial is testing

Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaNeoadjuvant
ZHOU FANGJIAN 298
Not applicableUnknownNCT05790122
What this trial is testing

Safety and Efficacy of Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1 Stage Renal Carcinoma

Who this might be right for
Carcinoma, Renal CellKidney Neoplasms
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 146
Large-scale testing (Phase 3)Study completedNCT00087022
What this trial is testing

Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Heidelberg Pharma AG 864
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272
What this trial is testing

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more
23andMe, Inc. 141
Not applicableStudy completedNCT00684645
What this trial is testing

Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 186
Testing effectiveness (Phase 2)Study completedNCT03679767
What this trial is testing

INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Who this might be right for
Metastatic Non-small Cell Lung CancerLocally Advanced Urothelial CancerMetastatic Urothelial Cancer+4 more
Incyte Corporation 121
Testing effectiveness (Phase 2)Active Not RecruitingNCT03228667
What this trial is testing

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung CancerUrothelial Carcinoma+10 more
ImmunityBio, Inc. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03172754
What this trial is testing

Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Fox Chase Cancer Center 98
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Testing effectiveness (Phase 2)Ended earlyNCT00303862
What this trial is testing

AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 10
Not applicableStudy completedNCT00537056
What this trial is testing

Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI

Who this might be right for
Kidney NeoplasmsCarcinoma, Renal CellKidney (Renal Cell) Cancer
Stanford University 17
Testing effectiveness (Phase 2)Ended earlyNCT00090870
What this trial is testing

PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Medical University of South Carolina 10
Testing effectiveness (Phase 2)Study completedNCT04337970
What this trial is testing

Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

Who this might be right for
Kidney CancerRenal Cell CarcinomaUnresectable Renal Cell Carcinoma+1 more
Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)UnknownNCT04134182
What this trial is testing

Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment.

Who this might be right for
Renal Cell Carcinoma
Kidney Cancer Research Bureau 8
Testing effectiveness (Phase 2)Study completedNCT01024205
What this trial is testing

Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Barts and the London School of Medicine and Dentistry 43
Next Page